Cardiology Experts


Executive Director
Taiwan liposaomal Companies


Dr. Hong joined the Liposome Research Laboratory (LRL) as a research scientist at the Cancer Research Institute of University of California, San Francisco for twenty years. After serving as a consultant to several biotechnology companies including Nycomed, Salutar, Onyx, and Sequus, he founded Taiwan Liposome Company (TLC) in Taiwan in 1997 and co-founded Hermes Biosciences in the United States in 1998. Dr. Hong has pioneered the study of the structure and function of biomembranes. With his long time devotion to the advancement of cancer therapy he has achieved a series of breakthroughs in drug carrier technology for improving drug and gene delivery and is an inventor on a number of patents. Dr. Hong received his B.S. in chemistry from Taiwan Cheng Kung University and M.S. in chemistry from the University of Texas at El Paso. He then earned a Ph.D. in Chemistry at the University of California at Berkeley and conducted postdoctoral research at Stanford University.

Research Interest

operation and management of modern Chinese medicine enterprises      

Global Experts from Taiwan

Global Experts in Subject

Share This Profile
Recommended Conferences
  • Gastroenterology and Hepatology April 24-25, 2019 Budapest | Hungary Theme: Novelties and Current Trends in Gastroenterology and GIT Disorders

    April 24-25, 2019 Budapest, Hungary

  • Hepatobiliary & Pancreatic Disorders September 17-18, 2018 | Philadelphia, Pennsylvania, USA Theme: Innovations in Research & the Treatment of Hepatobiliary & Pancreatic Diseases

    April 24-25, 2019 Budapest, Hungary

View more